Kura Oncology (KURA) Interest Coverage Ratio (QoQ) (2010 - 2026)
Kura Oncology (KURA) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Kura Oncology | 931.73 Mn | 931.73 Mn | 18.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.72% |
| Dec 31, 2025 | -58.18% |
| Sep 30, 2025 | -8,890.14% |
| Jun 30, 2025 | 98.99% |
| Mar 31, 2025 | -133.27% |
| Dec 31, 2024 | 470.98% |
| Sep 30, 2024 | -30.17% |
| Jun 30, 2024 | -2.68% |
| Dec 31, 2014 | 90.78% |
| Sep 30, 2014 | 10.16% |
| Jun 30, 2014 | -25.37% |
| Mar 31, 2014 | 47.73% |
| Dec 31, 2013 | -80.82% |
| Sep 30, 2013 | 36.27% |
| Jun 30, 2013 | -12.47% |
| Mar 31, 2013 | 42.40% |
| Dec 31, 2012 | -77.02% |
| Sep 30, 2012 | 6.32% |
| Jun 30, 2012 | -4.74% |
| Mar 31, 2012 | 57.31% |